Sperogenix Therapeutics and LUCA Healthcare Join Forces to Advance Digital Therapy for Myasthenia Gravis
China-based rare disease specialist Sperogenix Therapeutics Limited has entered into a partnership with compatriot firm...
Jiangxi Jemincare’s JYB1907 Receives NMPA Approval for Clinical Study in Solid Tumors
China-based Jiangxi Jemincare Group has announced that it has received approval from the China National...
NMPA Approves Suzhou MicroPort Joint Medical Technology’s Zirconium Niobium Alloy Femoral Head for Hip Replacement
The National Medical Products Administration (NMPA) has granted marketing approval to Suzhou MicroPort Joint Medical...
Cytocraft Biotech’s SDT-T002 Cell Therapy Approved for Advanced Liver Cancer by NMPA
China-based Cytocraft Biotech Development has announced that its cell therapy, SDT-T002, has obtained clinical trial...
Laekna Raises £791 Million in Hong Kong IPO for Pipeline Expansion
Sino-US Laekna (HKG: 2105) has successfully raised £791 million through an initial public offering (IPO)...
Grand Pharmaceutical’s STC3141 Achieves Clinical Endpoint in Sepsis Study
China-based Grand Pharmaceutical Group Limited (HKG: 0512) has announced that the Phase Ib REFINE study...
Everest Medicines Appoints Dr. Mike Berry as Chief Technology Officer to Drive Innovation
China-based Everest Medicines (HKG: 1952) has announced the appointment of Dr. Mike Berry as Chief...
AbbVie Inc. Files Lawsuit Against BeiGene Over BTK Inhibitor Brukinsa
US-based AbbVie Inc., (NYSE: ABBV), the company behind the first-in-class Bruton’s tyrosine kinase (BTK) inhibitor...
Janssen Submits Additional Indication Application to FDA for Carvykti in Multiple Myeloma
The Janssen subsidiary of Johnson & Johnson (J&J; NYSE: JNJ) has submitted an additional indication...
Dartsbio Pharmaceuticals and SIMM Receive NMPA Approval for ADC DS001 Clinical Trial
Guangdong-based antibody drug developer Dartsbio Pharmaceuticals has partnered with the Shanghai Institute of Materia Medica...
Hubei Guangji Pharmaceutical Partners with Jiangnan University for Green Manufacturing Innovation Lab
China-based Hubei Guangji Pharmaceutical Co., Ltd. (SHE: 000952) has announced a strategic partnership with Jiangnan...
Hybio Pharmaceutical’s Semaglutide API Receives FDA Review Acceptance
China-based Hybio Pharmaceutical Co., Ltd (SHE: 300199) has announced that the US Food and Drug...
YSB Inc. Lists on HKSE with HKD 363.6 Million IPO, Targeting Digital Pharma Services
China-based ex-hospital digital pharmaceutical service platform YSB Inc. (HKG: 9885) has successfully made its initial...
Ascletis Pharma Inc. Ceases Promotion of Hepatitis C Products and Halts Development of ASC06 and ASC09
China-based Ascletis Pharma Inc., (HKG: 1672) has announced significant business adjustments, including the decision to...
Mabwell Bioscience’s IL-11 mAb 9MW3811 Receives US FDA Clinical Trial Approval
China-based Mabwell (Shanghai) Bioscience Co., Ltd (SHA: 688062) has announced that it has received clinical...
NHSA Report Highlights ‘Flying Inspections’ Impact on Medical Insurance Fund Use in 2022
The National Healthcare Security Administration (NHSA) has released a report outlining the outcomes of ‘flying...
Hansoh Pharmaceutical Gets NMPA Approval for HIF-2α Inhibitor HS-10516 Clinical Study
China-based Hansoh Pharmaceutical Group Co., Ltd (HKG: 3692) has announced that it has received approval...
Sino Biopharmaceutical Secures Exclusive Rights to Gmax Biopharm’s GMA106 in Greater China
Sino Biopharmaceutical Ltd (HKG: 1177) through its subsidiary Chia Tai Tianqing Pharmaceutical Co., Ltd, has...
UIH Surgical to Invest RMB 2.5 Billion in Wuhan Medical Innovation and Robotics Base
United Imaging Healthcare Technology Co., Ltd (UIH), through its subsidiary UIH Surgical, has announced plans...
JJET’s IPO on STAR Market Accepted, Aims to Raise RMB 2.691 Billion for Medical Device Expansion
China-based JJET has received acceptance for its Initial Public Offering (IPO) filing on the Shanghai...